[1]
Powars DR, Hiti A, Ramicone E, Johnson C, Chan L. Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors. American journal of hematology. 2002 Jul:70(3):206-15
[PubMed PMID: 12111766]
Level 2 (mid-level) evidence
[2]
Serjeant GR. The natural history of sickle cell disease. Cold Spring Harbor perspectives in medicine. 2013 Oct 1:3(10):a011783. doi: 10.1101/cshperspect.a011783. Epub 2013 Oct 1
[PubMed PMID: 23813607]
Level 3 (low-level) evidence
[3]
Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine. 2005 Nov:84(6):363-376. doi: 10.1097/01.md.0000189089.45003.52. Epub
[PubMed PMID: 16267411]
Level 2 (mid-level) evidence
[4]
Hockham C, Piel FB, Gupta S, Penman BS. Understanding the contrasting spatial haplotype patterns of malaria-protective β-globin polymorphisms. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2015 Dec:36():174-183. doi: 10.1016/j.meegid.2015.09.018. Epub 2015 Sep 21
[PubMed PMID: 26394108]
Level 3 (low-level) evidence
[5]
Piel FB, Tatem AJ, Huang Z, Gupta S, Williams TN, Weatherall DJ. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. The Lancet. Global health. 2014 Feb:2(2):e80-9
[PubMed PMID: 24748392]
[6]
Abbott KC, Hypolite IO, Agodoa LY. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clinical nephrology. 2002 Jul:58(1):9-15
[PubMed PMID: 12141416]
[7]
Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Annals of internal medicine. 1991 Oct 15:115(8):614-20
[PubMed PMID: 1892333]
[8]
Akinsheye I, Solovieff N, Ngo D, Malek A, Sebastiani P, Steinberg MH, Chui DH. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. American journal of hematology. 2012 Feb:87(2):217-9. doi: 10.1002/ajh.22221. Epub 2011 Dec 3
[PubMed PMID: 22139998]
[9]
Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet (London, England). 2010 Dec 11:376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3
[PubMed PMID: 21131035]
[10]
Statius van Eps LW, Pinedo-Veels C, de Vries GH, de Koning J. Nature of concentrating defect in sickle-cell nephropathy. Microradioangiographic studies. Lancet (London, England). 1970 Feb 28:1(7644):450-2
[PubMed PMID: 4189754]
[11]
Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, Winaver J. Differential regulation of renal regional blood flow by endothelin-1. The American journal of physiology. 1996 Dec:271(6 Pt 2):F1166-72
[PubMed PMID: 8997390]
[12]
Scheinman JI. Sickle cell disease and the kidney. Nature clinical practice. Nephrology. 2009 Feb:5(2):78-88. doi: 10.1038/ncpneph1008. Epub 2008 Dec 2
[PubMed PMID: 19048000]
[13]
Elfenbein IB, Patchefsky A, Schwartz W, Weinstein AG. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. The American journal of pathology. 1974 Dec:77(3):357-74
[PubMed PMID: 4611224]
[14]
Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients. The American journal of medicine. 1975 Nov:59(5):650-9
[PubMed PMID: 128292]
[15]
Aygun B, Mortier NA, Smeltzer MP, Hankins JS, Ware RE. Glomerular hyperfiltration and albuminuria in children with sickle cell anemia. Pediatric nephrology (Berlin, Germany). 2011 Aug:26(8):1285-90. doi: 10.1007/s00467-011-1857-2. Epub 2011 May 11
[PubMed PMID: 21559933]
[16]
Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. The American journal of medicine. 1997 Feb:102(2):171-7
[PubMed PMID: 9217567]
[17]
Quek L, Sharpe C, Dutt N, Height S, Allman M, Awogbade M, Rees DC, Zuckerman M, Thein SL. Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. British journal of haematology. 2010 Apr:149(2):289-91. doi: 10.1111/j.1365-2141.2009.08062.x. Epub 2010 Jan 7
[PubMed PMID: 20064150]
[18]
Sharpe CC, Thein SL. Sickle cell nephropathy - a practical approach. British journal of haematology. 2011 Nov:155(3):287-97. doi: 10.1111/j.1365-2141.2011.08853.x. Epub 2011 Sep 9
[PubMed PMID: 21902687]
[19]
Alvarez O, Rodriguez MM, Jordan L, Sarnaik S. Renal medullary carcinoma and sickle cell trait: A systematic review. Pediatric blood & cancer. 2015 Oct:62(10):1694-9. doi: 10.1002/pbc.25592. Epub 2015 Jun 5
[PubMed PMID: 26053587]
Level 1 (high-level) evidence
[20]
Nasr SH, Markowitz GS, Sentman RL, D'Agati VD. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney international. 2006 Apr:69(7):1276-80
[PubMed PMID: 16482096]
[21]
Maigne G, Ferlicot S, Galacteros F, Belenfant X, Ulinski T, Niaudet P, Ronco P, Godeau B, Durrbach A, Sahali S, Lang P, Lambotte O, Audard V. Glomerular lesions in patients with sickle cell disease. Medicine. 2010 Jan:89(1):18-27. doi: 10.1097/MD.0b013e3181ca59b6. Epub
[PubMed PMID: 20075701]
[22]
Haymann JP, Stankovic K, Levy P, Avellino V, Tharaux PL, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clinical journal of the American Society of Nephrology : CJASN. 2010 May:5(5):756-61. doi: 10.2215/CJN.08511109. Epub 2010 Feb 25
[PubMed PMID: 20185605]
[23]
Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. Journal of the American Society of Nephrology : JASN. 2006 Aug:17(8):2228-35
[PubMed PMID: 16837635]
[24]
Sasongko TH, Nagalla S, Ballas SK. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. The Cochrane database of systematic reviews. 2015 Jun 4:2015(6):CD009191. doi: 10.1002/14651858.CD009191.pub3. Epub 2015 Jun 4
[PubMed PMID: 26041152]
Level 1 (high-level) evidence
[25]
Saxena AK, Panhotra BR, Al-Ghamdi AM. Should early renal transplantation be deemed necessary among patients with end-stage sickle cell nephropathy who are receiving hemodialytic therapy? Transplantation. 2004 Mar 27:77(6):955-6
[PubMed PMID: 15077050]
[26]
Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V. Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients. British journal of haematology. 2016 Jul:174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17
[PubMed PMID: 26992059]
Level 2 (mid-level) evidence
[27]
Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D. Renal lesions in sickle cell nephropathy in children. Nephron. 1985:39(4):352-5
[PubMed PMID: 3982580]
[28]
Huang E, Parke C, Mehrnia A, Kamgar M, Pham PT, Danovitch G, Bunnapradist S. Improved survival among sickle cell kidney transplant recipients in the recent era. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2013 Apr:28(4):1039-46. doi: 10.1093/ndt/gfs585. Epub 2013 Jan 22
[PubMed PMID: 23345624]
[29]
Almasri J, Tello M, Benkhadra R, Morrow AS, Hasan B, Farah W, Alvarez Villalobos N, Mohammed K, Allen JP, Prokop LJ, Wang Z, Kasiske BL, Israni AK, Murad MH. A Systematic Review for Variables to Be Collected in a Transplant Database for Improving Risk Prediction. Transplantation. 2019 Dec:103(12):2591-2601. doi: 10.1097/TP.0000000000002652. Epub
[PubMed PMID: 30768569]
Level 1 (high-level) evidence